Quell will no longer be available without a prescription after September 30. Quell Update Notice

Quell U.S. Patents

Neurometrix Inc. is a leading provider of advanced transcutaneous electrical nerve stimulation (TENS) systems. This page is intended to serve as notice under 35 U.S.C. § 287(a).

 

Product Names
Quell device, Quell 2.0 device, Quell Fibromyalgia device, Quell Electrodes, and Mobile and smartwatch apps U.S. Pat. Nos. 8,948,876; 9,474,898; 9,656,070; 9,675,801; 9,731,126; 9,827,420; 10,004,445; 10,112,040; 10,130,810; 10,159,835; 10,279,179; 10,293,159; 10,335,595; 10,384,063; 10,780,269; 10,864,365; 10,940,311; 11,058,877; 11,191,443; 11,235,142; 11,247,040; 11,247,052; 11,259,744; 11,511,106; 11,717,682; 11,730,959; D754,355; D837,394; D851,260; D857,910; D861,903; D862,716; D865,986; D958,381.
SENSUS device and SENSUS electrodes U.S. Pat. Nos. 8,948,876; 9,474,898; 9,656,070; 9,675,801; 9,731,126; 9,827,420; 10,004,445; 10,130,810; 10,159,835; 10,279,179; 10,335,595; 10,780,269; 11,191,443; 11,247,040; 11,247,052; 11,259,744; 11,717,682; D851,260; D716,457; D735,873.